Cardiac Monitors and Telemetry in ICU

Quick Answer

Cardiac monitoring in the ICU provides continuous surveillance of electrical activity, heart rate, rhythm, and ischemia detection. ECG acquisition uses surface electrodes measuring potential differences; standard configurations include 3-lead (Einthoven triangle, limited views), 5-lead (adds aVR-equivalent and V1), and 12-lead (full diagnostic capability). Continuous parameters monitored include heart rate (normal 60-100 bpm), rhythm identification, ST-segment analysis (>1 mm deviation alerts), and QTc interval (>500 ms concerning for Torsades). Alarm fatigue affects 72-99% of ICU alarms (false/non-actionable), contributing to sentinel events; management includes parameter individualization, delay settings, and smart alarm algorithms. Derived indices include heart rate variability (HRV) (reduced HRV predicts mortality, SDNN <50 ms high risk), and automated arrhythmia detection (sensitivity 80-95% for VT, but specificity limited by artifact). Telemetry systems transmit ECG wirelessly to central monitoring stations, enabling surveillance of step-down patients. Artifact recognition is critical: 60 Hz interference, motion artifact, electrode displacement, and muscle tremor can mimic pathology. Integration with clinical decision support improves sepsis detection, ischemia alerts, and arrhythmia management.

---

CICM Exam Focus

What Examiners Expect

Second Part Written (SAQ):

ECG monitoring is tested both as technical knowledge and clinical application

Common SAQ stems:

• "Describe the principles of ECG acquisition in the ICU, including lead placement and electrode-skin interface."
• "A patient on telemetry has multiple alarms. Discuss alarm fatigue, its consequences, and strategies for optimization."
• "Outline the parameters that can be continuously monitored from a cardiac monitor and describe their clinical utility."
• "Describe QTc monitoring in the ICU, including causes of prolongation and management strategies."
• "You are shown this ECG rhythm strip. Identify the artifact and describe how you would troubleshoot."

Recent SAQ themes (2020-2025):

• 2024: "Describe the role of heart rate variability analysis in the critically ill patient."
• 2023: "Outline the principles and limitations of automated arrhythmia detection algorithms."
• 2022: "Discuss the physiological basis of ST-segment monitoring and its clinical applications in the ICU."
• 2021: "A patient has artifact on their cardiac monitor. Describe systematic troubleshooting."
• 2020: "Compare 3-lead, 5-lead, and 12-lead ECG monitoring in the ICU setting."

Second Part Hot Case:

Typical presentations involving cardiac monitoring:

• Post-cardiac surgery patient with arrhythmia on telemetry
• Septic patient with reduced HRV and new arrhythmia
• Patient with QT-prolonging medications requiring monitoring
• Frequent monitor alarms in confused/agitated patient

Examiners assess:

• Systematic approach to rhythm interpretation
• Recognition of artifact vs true arrhythmia
• Understanding of monitoring limitations
• Integration with clinical picture and management

Second Part Viva:

Expected discussion areas:

• Physics of ECG acquisition (electrode-skin interface, signal processing)
• Lead placement systems (Einthoven, Mason-Likar, 12-lead)
• Alarm management strategies (individualization, delay, smart algorithms)
• QTc calculation methods (Bazett, Fridericia, Framingham)
• HRV indices and their clinical significance
• Telemetry vs hardwire monitoring indications
• Arrhythmia detection sensitivity and specificity

Examiner expectations:

• Understand the technical basis of cardiac monitoring
• Articulate a systematic approach to alarm management
• Discuss evidence for monitoring practices
• Recognize limitations and pitfalls of automated systems

Common Mistakes

• Confusing motion artifact with ventricular tachycardia
• Using Bazett formula for QTc at high heart rates (overestimates)
• Not understanding that 3-lead monitoring misses right coronary and circumflex ischemia
• Ignoring alarm fatigue as a patient safety issue
• Not recognizing electrode displacement as cause of "STEMI"
• Failing to troubleshoot before treating apparent arrhythmia
• Over-reliance on automated arrhythmia detection without visual confirmation

---

Key Points

Must-Know Facts

1. ECG Signal Origin: Surface ECG measures potential differences generated by cardiac depolarization/repolarization; signal amplitude 0.5-3 mV at skin surface; requires amplification (gain 1000x) and filtering (0.05-150 Hz diagnostic, 0.5-40 Hz monitoring mode)

2. 3-Lead vs 5-Lead vs 12-Lead: 3-lead monitors leads I, II, III (limited ischemia detection); 5-lead adds aVR, aVL, aVF equivalents plus V1 (anterior view); 12-lead provides complete diagnostic capability with full precordial leads

3. Lead II Preference: Lead II typically used for rhythm monitoring (P-waves most visible, parallel to right atrium-to-apex vector); Lead V1 preferred for differentiating SVT with aberrancy from VT (RBBB morphology analysis)

4. Alarm Fatigue: 72-99% of cardiac alarms are false or non-actionable (PMID: 25800287); contributes to 3rd leading cause of sentinel events (The Joint Commission 2014); average ICU has 150-400 alarms/patient/day

5. ST-Segment Monitoring: Continuous ST analysis detects ischemia before hemodynamic changes; threshold typically >1 mm deviation from baseline for 60 seconds; sensitivity 80-90% but lower specificity (60-75%) due to non-ischemic causes

6. QTc Prolongation: QTc >500 ms indicates high Torsades risk; Bazett formula (QTc = QT/√RR) overestimates at high HR, underestimates at low HR; Fridericia (QTc = QT/∛RR) more accurate at extremes

7. Heart Rate Variability (HRV): Reduced HRV predicts mortality in sepsis, post-MI, heart failure; SDNN <50 ms = high risk; very low-frequency (VLF), low-frequency (LF), high-frequency (HF) components reflect autonomic tone

8. Arrhythmia Detection Algorithms: Sensitivity for VT 80-95%, VF 92-99%; specificity limited (60-80%) due to artifact, noise, and morphology variation; require visual confirmation before therapy

9. Electrode-Skin Interface: Impedance ideally <5 kΩ; high impedance causes baseline wander, reduced amplitude; proper skin preparation (abrasion, alcohol, gel electrodes) essential

10. Telemetry Indications: Step-down/ward monitoring for cardiac patients; wireless transmission to central station; lower nurse-to-patient ratios than ICU; bridges continuous to intermittent monitoring

Memory Aids

Mnemonic LEADS: Lead placement troubleshooting

• L: Location verification (correct anatomical position)
• E: Electrode condition (gel, adhesion, expiry)
• A: Artifact identification (motion, interference)
• D: Damping/filtering settings check
• S: Skin preparation (abrasion, cleaning)

Mnemonic ALARM: Alarm optimization strategies

• A: Adjust thresholds to individual patient
• L: Lengthen delay before alarming (unless life-threatening)
• A: Assess and eliminate artifact sources
• R: Replace electrodes and cables regularly
• M: Monitor-specific training for staff

QTc Rule of 500: QTc >500 ms = high Torsades risk; requires intervention (discontinue offending drugs, correct electrolytes, consider magnesium, temporary pacing for bradycardia-dependent)

---

Definition and Epidemiology

Definition

Cardiac monitoring refers to the continuous surveillance of cardiac electrical activity using surface electrodes and electronic processing equipment. The system captures, amplifies, filters, and displays the electrocardiogram (ECG) in real-time, enabling detection of rate abnormalities, rhythm disturbances, conduction defects, and ischemia.

Components of Cardiac Monitoring System:

1. Surface electrodes: Ag/AgCl gel electrodes attached to skin
2. Lead wires: Connect electrodes to patient cable
3. Patient cable: Transmits signal to bedside monitor (hardwire) or telemetry transmitter (wireless)
4. Signal processor: Amplifies (1000x), filters (0.05-150 Hz), digitizes signal
5. Display unit: Waveform display, numerical parameters, alarms
6. Central station (telemetry): Remote surveillance capability
7. Archival storage: Trend data, event recall, documentation

Telemetry specifically refers to wireless ECG monitoring that transmits data from a portable transmitter worn by the patient to a central monitoring station, enabling surveillance of patients outside the immediate ICU environment.

Epidemiology

Utilization in ICU:

• Continuous cardiac monitoring: 100% of ICU patients (universal standard of care)
• Telemetry monitoring: 10-15% of hospital beds in developed countries (PMID: 24636883)
• 12-lead ECG acquisition capability: Standard in all Australian Level III ICUs

Alarm Burden Data (PMID: 25800287):

• Average alarms per patient per day: 150-400 in ICU
• False/non-actionable alarms: 72-99%
• Nursing response time increase: Alarm fatigue leads to median 10-minute delay (vs 4 minutes for clinical alarms)
• Sentinel events: Alarm fatigue identified in 3.5% of Joint Commission sentinel events

Australian/NZ Data (ANZICS-CORE):

• All Level II and III ICUs maintain continuous cardiac monitoring
• Telemetry widely available in coronary care units and step-down units
• National variation in alarm management protocols
• ANZICS recommends regular review of alarm parameters (IC-1 Minimum Standards)

Arrhythmia Detection (PMID: 15078800):

• Atrial fibrillation in ICU: 10-15% of admissions, up to 50% post-cardiac surgery
• Ventricular arrhythmias: 5-15% of ICU patients experience >1 VT episode
• Missed arrhythmias: False negative rate 5-20% depending on algorithm and artifact burden

---

Applied Basic Sciences

Physics of ECG Acquisition

Cardiac Electrical Activity

The ECG records potential differences generated by the summated electrical activity of cardiac myocytes. Each cardiac cycle produces characteristic deflections (PMID: 25432557):

1. P wave: Atrial depolarization (duration 80-120 ms, amplitude <2.5 mm)
2. PR interval: Conduction through AV node (120-200 ms)
3. QRS complex: Ventricular depolarization (60-100 ms)
4. ST segment: Isoelectric plateau between depolarization and repolarization
5. T wave: Ventricular repolarization
6. QT interval: Total ventricular electrical activity

Signal Characteristics:

• Amplitude at skin surface: 0.5-3 mV
• Frequency content: 0.05-150 Hz (diagnostic), 0.5-40 Hz (monitoring)
• Dominant frequency: 10-25 Hz for QRS complex

Electrode-Skin Interface

The electrode-skin interface determines signal quality (PMID: 26161986):

Components:

1. Skin barrier: Stratum corneum (high impedance layer ~50-500 kΩ)
2. Electrolyte gel: Conducts ions between electrode and skin
3. Silver/silver chloride (Ag/AgCl) electrode: Converts ionic current to electrical current

Impedance Optimization:

• Target impedance: <5 kΩ (ideally <2 kΩ)
• Skin preparation: Mild abrasion removes stratum corneum
• Electrode placement: Avoid bony prominences, areas of movement
• Gel condition: Fresh, adequate volume, not dried out

Half-Cell Potential: The Ag/AgCl electrode generates a stable half-cell potential (approximately +222 mV vs standard hydrogen electrode), allowing accurate measurement of small cardiac signals.

Signal Processing

Amplification (PMID: 24248647):

• Input signal: ~1 mV
• Output signal: ~1 V (1000x gain)
• Differential amplification: Measures difference between electrodes, rejects common-mode noise
• Common Mode Rejection Ratio (CMRR): >100 dB ideal (rejects 60 Hz power line interference)

Filtering:

• High-pass filter: Removes baseline wander (set at 0.05 Hz diagnostic, 0.5 Hz monitoring)
• Low-pass filter: Removes high-frequency noise (150 Hz diagnostic, 40 Hz monitoring)
• Notch filter: 50/60 Hz removes power line interference
• Diagnostic vs Monitoring Mode: Monitoring mode uses more aggressive filtering, may distort ST segments

Digitization:

• Analog-to-digital conversion: 12-16 bit resolution
• Sampling rate: 250-500 Hz (minimum 150 Hz for accurate QRS detection)
• Nyquist theorem: Sampling rate must be >2x highest frequency of interest

Lead Systems and Placement

Einthoven Triangle (3-Lead System)

Willem Einthoven's original bipolar limb leads form an equilateral triangle around the heart (PMID: 17565385):

Lead I: Right arm (−) to left arm (+)

• Views lateral wall
• P wave usually positive

Lead II: Right arm (−) to left foot (+)

• Views inferior wall
• P wave most prominent (rhythm monitoring lead of choice)
• Parallel to atrial depolarization vector

Lead III: Left arm (−) to left foot (+)

• Views inferior wall
• Variable P wave morphology

ICU Electrode Placement (Modified Limb Leads):

• Right arm electrode: Right infraclavicular fossa
• Left arm electrode: Left infraclavicular fossa
• Left leg electrode: Left lower chest/abdomen
• Right leg electrode: Right lower chest (ground/reference)

5-Lead System

Adds a precordial electrode to the 3-lead system (PMID: 15078800):

Additional Views:

• aVR, aVL, aVF (augmented limb leads) derived mathematically
• V1 position: 4th intercostal space, right sternal border
• Can derive V2-V6 equivalents with different V-lead positions

Clinical Advantage:

• V1 (MCL1): Excellent for wide complex tachycardia differentiation
• Provides anterior wall ST-segment monitoring
• Better bundle branch block identification

V Lead Position Options:

• V1 standard: Right ventricular/septal view
• V5 position: Lateral wall ischemia detection
• Lewis lead (right atrial position): Enhanced P-wave visualization for atrial flutter diagnosis

12-Lead ECG

Full diagnostic capability with 6 limb leads + 6 precordial leads (PMID: 28974521):

Precordial Lead Positions:

• V1: 4th ICS, right sternal border (septal)
• V2: 4th ICS, left sternal border (septal)
• V3: Between V2 and V4 (anterior)
• V4: 5th ICS, midclavicular line (anterior)
• V5: 5th ICS, anterior axillary line (lateral)
• V6: 5th ICS, midaxillary line (lateral)

Coronary Territory Mapping:

Mason-Likar Modification: Limb electrodes placed on torso for continuous monitoring (PMID: 25432557):

• May alter axis by 15-30 degrees
• Can reduce inferior Q-wave amplitude (may mask inferior MI)
• Reduces motion artifact compared to true limb placement

Specialized Lead Configurations

Right-Sided Leads (V3R-V6R):

• Mirror positions on right chest
• V4R most sensitive for RV infarction (sensitivity 93%)
• Indicated when inferior STEMI suspected

Posterior Leads (V7-V9):

• V7: Posterior axillary line, 5th ICS
• V8: Tip of scapula, 5th ICS
• V9: Left paraspinal, 5th ICS
• Detect posterior STEMI (>0.5 mm ST elevation diagnostic)

Lewis Lead (S5 Configuration):

• Optimized for P-wave visualization
• RA electrode: 2nd ICS, right sternal border
• LA electrode: 4th ICS, right sternal border
• LL electrode: Right lower rib cage
• Monitor lead I: Enhanced atrial activity visualization

Continuous Monitoring Parameters

Heart Rate Monitoring

Rate Calculation Methods (PMID: 22573892):

1. R-R Interval Method: HR = 60/RR interval (seconds)

   • Most accurate instantaneous rate
   • Affected by irregular rhythms

2. Averaging Method: Mean of last 3-5 RR intervals

   • Reduces variability display
   • Standard for most monitors

3. Trend Averaging: Moving average over 10-30 seconds

   • Smooths display
   • May delay detection of sudden changes

Heart Rate Alarm Thresholds:

• Tachycardia: Typically set >120-150 bpm (individualize)
• Bradycardia: Typically set <50-60 bpm (individualize)
• Pause/Asystole: Usually >3-4 seconds

Clinical Considerations:

• Pacemaker patients: May require different algorithm (pace spike detection)
• Post-cardiac surgery: Wider thresholds due to expected variability
• Beta-blocker therapy: Lower bradycardia threshold

Rhythm Monitoring and Arrhythmia Detection

Automated Detection Algorithms (PMID: 28974521):

Modern cardiac monitors use pattern recognition algorithms to detect:

1. Supraventricular Arrhythmias:

   • Atrial fibrillation: Irregular RR intervals + absent P waves
   • Atrial flutter: Sawtooth pattern at 250-350 bpm
   • SVT: Regular narrow complex tachycardia

2. Ventricular Arrhythmias:

   • PVCs: Wide complex, compensatory pause
   • VT: Wide complex tachycardia (>100 bpm, >3 consecutive)
   • VF: Chaotic, irregular deflections

3. Conduction Abnormalities:

   • Heart block: PR prolongation, dropped beats, dissociation
   • Bundle branch block: Wide QRS with characteristic morphology
   • Pause/asystole: No QRS for defined period

Detection Performance (PMID: 18436645):

Limitations:

• Motion artifact: May mimic VT/VF (leading cause of false alarms)
• Noise: High-frequency interference may trigger inappropriate alarms
• Lead disconnection: May appear as asystole or artifact
• Pacemaker spikes: May confuse QRS detection

ST-Segment Monitoring

Physiological Basis (PMID: 28974521):

ST-segment changes reflect myocardial ischemia through altered repolarization:

• ST Depression: Subendocardial ischemia, digoxin effect, hypokalemia, LVH
• ST Elevation: Transmural ischemia, pericarditis, early repolarization, LV aneurysm

Monitoring Setup:

1. Baseline establishment: J-point + 60-80 ms measurement point
2. Lead selection: Ideally 12-lead; minimum leads II, V1, V5 for 3-territory coverage
3. Threshold: Typically >1 mm deviation from baseline for >60 seconds
4. Trend display: Continuous ST-segment trend over time

Clinical Applications:

• Post-ACS: Early detection of re-occlusion
• Post-PCI: Stent thrombosis detection
• Cardiac surgery: Graft patency monitoring
• High-risk non-cardiac surgery: Perioperative ischemia

Evidence for ST Monitoring (PMID: 15078800):

• 80-90% sensitivity for ischemia detection
• Precedes hemodynamic changes by minutes to hours
• May reduce cardiac mortality in high-risk patients (observational data)

Limitations:

• LBBB, paced rhythms: Baseline ST changes obscure ischemia
• LVH: ST depression at baseline
• Non-diagnostic filter: May distort ST segment (use diagnostic mode)
• Patient movement: Position changes alter baseline

QTc Interval Monitoring

Significance (PMID: 30285201):

Prolonged QT interval increases risk of:

• Torsades de Pointes (polymorphic VT)
• Sudden cardiac death

QT Measurement:

• From QRS onset to end of T wave
• Measure in lead with longest QT and distinct T wave (usually V2-V3 or lead II)
• Avoid leads with U waves or flat T waves

QTc Correction Formulas (PMID: 27317349):

Automated QTc Monitoring:

• Modern monitors calculate QTc automatically
• Accuracy depends on T wave recognition
• Manual verification recommended for borderline values

QTc Thresholds:

• Normal: <450 ms (males), <460 ms (females)
• Borderline: 450-500 ms
• Prolonged: >500 ms (high risk for Torsades)
• Critical: >550 ms or >60 ms increase from baseline

ICU QT-Prolonging Factors (PMID: 23787442):

---

Derived Indices

Heart Rate Variability (HRV)

Definition and Physiology (PMID: 17054163):

HRV measures beat-to-beat variation in RR intervals, reflecting autonomic nervous system modulation of cardiac function.

Autonomic Influences:

• Parasympathetic (vagal): Rapid, beat-to-beat modulation; high-frequency oscillations
• Sympathetic: Slower modulation; low-frequency oscillations
• Baroreflex: Contributes to both LF and HF components

Time-Domain Measures:

Frequency-Domain Measures:

Clinical Applications in ICU (PMID: 19409002):

1. Sepsis Prognostication:

   • Reduced HRV (SDNN <50 ms) predicts mortality
   • Sensitivity 77%, specificity 88% for poor outcome
   • Loss of variability precedes clinical deterioration

2. Post-MI Risk Stratification:

   • SDNN <70 ms = 3.2x mortality risk
   • Standard component of risk assessment

3. Brain Death Assessment:

   • Absent HRV supports diagnosis
   • Loss of respiratory sinus arrhythmia

4. Weaning from Mechanical Ventilation:

   • Improved HRV during SBT predicts successful weaning
   • LF/HF ratio changes indicate stress response

Limitations:

• Requires sinus rhythm for accurate analysis
• Atrial fibrillation, frequent ectopy invalidate measurements
• Short recording periods less reliable than 24-hour analysis
• Medication effects (beta-blockers, sedatives) alter HRV

QT Dispersion

Definition (PMID: 9727678): QT dispersion (QTd) is the difference between maximum and minimum QT intervals across 12 leads, reflecting regional heterogeneity of repolarization.

Calculation: QTd = QTmax - QTmin

Normal Values: <50 ms

Clinical Significance:

• QTd >100 ms associated with increased arrhythmia risk
• Predicts sudden cardiac death in post-MI patients
• Reflects pro-arrhythmic substrate

Limitations:

• Poor reproducibility
• Technique-dependent measurement
• Largely replaced by other risk markers

Arrhythmia Burden Quantification

Modern monitors calculate:

• PVC burden: Number/percentage of ventricular ectopy
• AF burden: Percentage of time in atrial fibrillation
• Pause frequency: Number and duration of pauses
• Arrhythmia trends: Graphical display of arrhythmia density over time

Clinical Relevance:

• PVC burden >10% associated with cardiomyopathy risk
• AF burden guides anticoagulation decisions
• Trend analysis identifies deterioration patterns

---

Alarm Management

The Alarm Fatigue Problem

Epidemiology (PMID: 25800287):

Contributing Factors:

1. Technical factors: Artifact, poor signal quality, inappropriate thresholds
2. Clinical factors: Patient movement, electrode displacement, transient benign arrhythmias
3. System factors: Default (not individualized) alarm settings, redundant alarms
4. Human factors: Alarm overload, cognitive fatigue, alarm normalization

Consequences of Alarm Fatigue (PMID: 26162509):

• Delayed or no response to true critical alarms
• Patient deaths (documented cases of VF missed due to ignored alarms)
• Nursing stress and burnout
• Family distress and disruption
• Decreased alarm credibility

Alarm Optimization Strategies

1. Parameter Individualization (PMID: 28974521):

Adjust alarm thresholds based on:

• Patient baseline (e.g., heart rate thresholds for beta-blocked patients)
• Clinical condition (wider thresholds for stable patients)
• Therapeutic goals (tighter thresholds for acute MI)

Recommended Approach:

• Review and adjust within 2 hours of admission
• Daily review during rounds
• Document clinical rationale for changes

2. Delay Settings:

3. Smart Alarm Algorithms (PMID: 29406844):

Advanced monitors incorporate:

• Pattern recognition: Distinguishes artifact from true arrhythmia
• Multi-parameter integration: Correlates ECG with SpO2, BP, respiration
• Cascading alarms: Initial advisory before critical alarm
• Machine learning: Continuously improves specificity

4. Staff Education and Workflow:

• Regular alarm response training
• Daily electrode and lead wire checks
• Skin preparation protocols
• Escalation pathways
• Multidisciplinary alarm committee

5. Noise Reduction:

• Proper skin preparation (reduces impedance)
• Electrode replacement every 24-48 hours
• Cable management (reduce movement artifact)
• Appropriate filter selection

Alarm Hierarchy and Prioritization

Crisis Alarms (immediate response):

• Ventricular fibrillation
• Asystole
• Ventricular tachycardia (if hemodynamically significant)

Warning Alarms (prompt response):

• Significant bradycardia or tachycardia
• ST-segment changes
• High-grade heart block

Advisory Alarms (timely response):

• PVC frequency
• Technical issues
• Borderline parameters

Australian/NZ Context:

• ANZICS Minimum Standards recommend:
  • Audible alarms for all monitored parameters
  • Visible alarm indicators
  • Central alarm capability
  • Regular alarm review and optimization
• No mandated alarm settings, but regular audit recommended

---

Artifact Recognition and Troubleshooting

Common Artifacts

1. Baseline Wander

Appearance: Slow undulation of isoelectric line (frequency <0.5 Hz)

Causes:

• Respiration (most common)
• Patient movement
• Poor electrode contact
• Gel drying

Troubleshooting:

• Increase high-pass filter (0.5 Hz monitoring mode)
• Replace electrodes
• Reposition electrodes away from respiratory movement
• Ensure adequate skin preparation

Clinical Impact: May affect ST-segment measurement accuracy

2. Power Line (50/60 Hz) Interference

Appearance: Regular, fine oscillations superimposed on ECG

Causes:

• Electromagnetic interference from AC power
• Poor grounding
• High electrode impedance
• Nearby electrical equipment

Troubleshooting:

• Activate notch filter (50 Hz in Australia/NZ, 60 Hz in Americas)
• Check electrode impedance
• Move equipment away from patient
• Ensure proper grounding

Clinical Impact: May obscure fine waveform details (P waves, pacemaker spikes)

3. Motion Artifact (Tremor)

Appearance: Irregular, high-frequency baseline disturbance; may mimic VT/VF

Causes:

• Patient movement
• Shivering/tremor (hypothermia, Parkinson's)
• Muscle activity (seizure)
• External manipulation (chest physiotherapy)

Troubleshooting:

• Treat underlying cause (warming for hypothermia)
• Move electrodes to areas of less muscle mass
• Restrain leads to reduce cable movement
• Increase low-pass filter (reduces high-frequency noise)

Clinical Impact: Major cause of false VT/VF alarms and inappropriate shocks

4. Electrode Displacement

Appearance: Sudden change in waveform morphology or axis

Causes:

• Electrode detachment
• Lead wire disconnection
• Patient repositioning
• Diaphoresis reducing adhesion

Troubleshooting:

• Check all electrode attachments
• Replace displaced electrodes
• Ensure dry skin before reapplication
• Consider alternative electrode type (wet-gel vs hydrogel)

Clinical Impact: May mimic acute ischemia or arrhythmia

5. Lead Reversal

Appearance: Inverted or abnormal waveforms in specific leads

Common Patterns:

• RA-LA reversal: Inverted P, QRS, T in lead I; leads II and III reversed
• RA-LL reversal: Flat lead II, leads I and III swapped
• Precordial reversal: Abnormal R-wave progression

Troubleshooting:

• Systematic electrode position verification
• Compare with previous ECGs

Clinical Impact: May mask ischemia or arrhythmia in affected leads

Systematic Troubleshooting Approach

Step 1: Patient Assessment

• Is the patient clinically stable?
• Does the monitor correlate with clinical findings (pulse, consciousness)?
• Rule out true emergency before troubleshooting

Step 2: Equipment Check

• Electrode adhesion and gel condition
• Lead wire connections
• Cable integrity
• Monitor settings

Step 3: Signal Optimization

• Skin preparation (abrade, clean, dry)
• Electrode replacement
• Lead repositioning if needed
• Filter adjustment

Step 4: System Verification

• Compare with another lead
• Perform 12-lead ECG if indicated
• Check pulse oximetry pleth for correlation

Step 5: Documentation

• Record troubleshooting steps
• Document artifact episodes
• Adjust alarm settings if appropriate

---

Telemetry Systems

System Architecture

Components (PMID: 24636883):

1. Transmitter Unit:

   • Worn by patient (belt clip, pouch, or lanyard)
   • Battery-powered (24-72 hour life)
   • Electrodes connect via standard lead wires
   • Transmits wirelessly to receiver

2. Receiver/Antenna Network:

   • Distributed throughout monitored area
   • Provides redundant coverage
   • Signal processing and handoff between zones

3. Central Monitoring Station:

   • Multi-patient display (typically 16-64 patients)
   • Alarm annunciation
   • Arrhythmia detection and storage
   • Trend display and analysis

4. Communication Integration:

   • Alarm forwarding to mobile devices
   • Integration with nurse call systems
   • Electronic medical record interface

Wireless Technologies

Common Transmission Methods:

Australian Considerations:

• ACMA (Australian Communications and Media Authority) regulates medical device frequencies
• ISM band (915 MHz centre) commonly used
• Hospital IT infrastructure requirements for Wi-Fi-based systems

Indications for Telemetry Monitoring

Appropriate Use Criteria (PMID: 15078800):

Duration Guidelines:

• Generally 24-48 hours for most indications
• Longer for high-risk patients or ongoing arrhythmia
• Discontinue when indication resolved and patient stable

Central Station Monitoring

Staffing Requirements (PMID: 26162509):

• Dedicated monitor technician recommended for >16 patients
• Continuous surveillance 24/7
• Clear escalation protocols
• Regular competency assessment

Documentation Requirements:

• Rhythm strips at admission, every shift, and with changes
• Alarm acknowledgment logs
• Arrhythmia event storage
• Trend data retention

Central Station Features:

• Multi-patient waveform display
• Automated arrhythmia analysis
• ST-segment trending
• Alarm history and statistics
• Remote printing capability
• Secondary alarming to mobile devices

---

Integration with Clinical Decision Support

Automated Sepsis Detection

Concept (PMID: 29261571): Integration of cardiac monitoring data with clinical decision support systems for early sepsis detection.

Heart Rate-Based Markers:

• Persistent tachycardia (HR >90 for >2 hours)
• Reduced heart rate variability
• Heart rate not responsive to fever (relative bradycardia with specific pathogens)

Multi-Parameter Integration: Combining cardiac monitoring with:

• Respiratory rate (RR >22)
• Blood pressure (SBP <100 or MAP <65)
• Temperature
• SpO2

Evidence:

• Automated alerts increase sepsis bundle compliance (PMID: 27270178)
• Earlier antibiotic administration (60-90 minute improvement)
• Reduced mortality in some studies (20-30% relative reduction)

Ischemia Alert Systems

Components:

• Continuous ST-segment monitoring
• Threshold-based alerting
• Trend analysis with deviation detection

Integration Features:

• Automatic 12-lead acquisition on ST alert
• Page/notification to cardiology team
• Documentation in EHR with alert timestamp

Evidence (PMID: 18036161):

• Reduces time to intervention in acute ischemia
• May improve outcomes post-PCI (stent thrombosis detection)
• Cost-effective in high-risk populations

Arrhythmia Management Protocols

Decision Support Integration:

1. New Atrial Fibrillation:

   • Alert triggers risk score calculation (CHA2DS2-VASc)
   • Suggests anticoagulation consideration
   • Documents duration for rhythm control decisions

2. Bradyarrhythmias:

   • Quantifies pause duration and frequency
   • Correlates with symptoms
   • Suggests pacing evaluation if indicated

3. Ventricular Arrhythmias:

   • PVC burden calculation
   • VT detection with morphology storage
   • Triggers electrophysiology consultation for sustained VT

Data Analytics and Machine Learning

Emerging Applications (PMID: 31478794):

1. Predictive Analytics:

   • Early warning for cardiac arrest (hours before event)
   • AF onset prediction
   • Decompensation prediction integrating HRV trends

2. Pattern Recognition:

   • Improved artifact rejection
   • Personalized normal ranges based on patient data
   • Identification of subtle arrhythmias

3. Outcome Prediction:

   • Mortality risk based on HRV patterns
   • ICU length of stay prediction
   • Readmission risk stratification

Challenges:

• Validation required before clinical implementation
• Regulatory approval pathways
• Integration with existing hospital systems
• Alert fatigue with additional notifications

---

Australian/NZ Context

ANZICS Standards

Minimum Standards for ICU (IC-1) (ANZICS-CORE):

• Continuous cardiac monitoring for all Level II and III ICU patients
• Visible and audible alarms
• Central alarm capability required
• Regular equipment maintenance and calibration

Recommendations:

• Staff trained in alarm interpretation and response
• Protocols for alarm escalation
• Documentation of rhythm and monitoring parameters
• Regular review of alarm settings

Equipment Standards

TGA (Therapeutic Goods Administration):

• All cardiac monitors must be TGA-approved medical devices
• Regular maintenance and calibration requirements
• Incident reporting for device failures

AS/NZS Standards:

• AS 3919: Medical electrical equipment - ECG monitors
• IEC 60601-2-27: Particular requirements for ECG monitoring equipment

Indigenous Health Considerations

Health Disparities:

• Aboriginal and Torres Strait Islander peoples have higher rates of:

  • Coronary artery disease (2-3x higher age-standardized mortality)
  • Atrial fibrillation (associated with rheumatic heart disease)
  • Heart failure requiring ICU admission

• Māori populations in NZ have:

  • Higher cardiovascular mortality
  • Increased rates of rheumatic heart disease

Monitoring Implications:

• Higher index of suspicion for ischemia in Indigenous patients
• Consider rheumatic heart disease as cause of arrhythmias
• Cultural considerations in alarm communication and family presence
• Ensure monitoring plans discussed with whānau/family
• Aboriginal Health Worker/Liaison Officer involvement

Practical Considerations:

• Skin preparation may need modification for different skin types
• Electrode adhesion may vary
• Explanation of monitoring equipment to family members important
• Documentation of culturally appropriate communication

Remote and Retrieval Medicine

RFDS and Aeromedical Context:

• Portable cardiac monitors essential for retrieval
• Limited alarm response capability in flight
• Pre-flight arrhythmia assessment critical
• Telemetry to receiving hospital when available

Telemedicine Integration:

• ECG transmission to specialist review
• Real-time consultation capability
• Store-and-forward for rhythm analysis
• Rural/remote hospital support networks

---

Monitoring in Special Populations

Post-Cardiac Surgery

Standard Monitoring:

• Continuous 5-lead or 12-lead ECG
• Temporary pacemaker capability (epicardial wires)
• ST-segment monitoring in all coronary territories

Common Arrhythmias (PMID: 26490697):

• Atrial fibrillation: 30-50% post-CABG
• Ventricular arrhythmias: 1-5% sustained VT/VF
• Conduction disturbances: 1-2% requiring permanent pacing

Special Considerations:

• Pacemaker spikes may affect detection algorithms
• Temporary wire sensing for backup
• Wider alarm thresholds initially, titrate as patient stabilizes

Hypothermia (Therapeutic or Accidental)

ECG Changes:

• J (Osborn) waves: Positive deflection at J-point
• Prolonged PR, QRS, QT intervals
• Bradycardia
• Atrial fibrillation common at <32°C
• VF risk increases at <28°C

Monitoring Implications:

• Adjust alarm thresholds for expected bradycardia
• QTc monitoring critical during rewarming
• Arrhythmia suppression during cooling, emergence during rewarming

Electrolyte Abnormalities

Hyperkalemia ECG Changes (PMID: 24612908):

• Peaked T waves (mild, K+ 5.5-6.5)
• Prolonged PR, flattened P waves (moderate, K+ 6.5-7.5)
• Widened QRS (severe, K+ >7.5)
• Sine wave pattern (pre-arrest)
• VF risk

Hypokalemia ECG Changes:

• ST depression
• T wave flattening/inversion
• Prominent U waves
• Prolonged QT
• Increased Torsades risk

Monitoring Requirements:

• Continuous monitoring during potassium replacement
• QTc monitoring for hypokalemia
• Widened QRS alerts for hyperkalemia

Medications Affecting Monitoring

QT-Prolonging Drugs:

• Baseline and regular QTc monitoring
• Consider alternative agents if QTc >500 ms
• Correct electrolytes before initiating

Beta-Blockers:

• Adjust bradycardia alarms
• Expected reduced HRV
• Consider in alarm threshold documentation

Antiarrhythmic Drugs:

• Amiodarone: QT prolongation, bradycardia
• Sotalol: QT prolongation, Torsades risk
• Flecainide: QRS widening

---

Complications and Adverse Events

Direct Monitoring Complications

Electrode-Related:

• Skin irritation/allergic reaction: 5-10% of prolonged monitoring
• Skin breakdown: Risk with poor adhesion and frequent replacement
• Pain with adhesive removal

Prevention:

• Rotate electrode sites when possible
• Hypoallergenic electrodes available
• Barrier creams for sensitive skin

Alarm-Related Adverse Events

Documented Harms (PMID: 26162509):

• Missed arrests due to alarm fatigue (fatal outcomes reported)
• Inappropriate cardioversion for artifact misidentified as VF
• Delayed intervention for true arrhythmias
• Psychological distress (patients and families)

Risk Mitigation:

• Alarm optimization protocols
• Regular education and competency assessment
• Incident reporting and learning systems
• Patient/family education about alarm meaning

System Failure Considerations

Backup Requirements:

• Battery backup for bedside monitors
• Manual pulse check capability
• Alternative monitoring (pulse oximetry plethysmography)
• Clinical vigilance not replaced by monitoring

Failure Mode Recognition:

• Display failure vs cardiac event
• Communication system failure
• Network/telemetry system outage

---

Progressive Difficulty Assessments

Basic Level (Foundation)

Multiple Choice Questions:

1. Which lead is most commonly used for continuous rhythm monitoring? a) Lead I b) Lead II c) Lead V1 d) Lead aVF

   Answer: b) Lead II - provides best visualization of P waves as it is parallel to atrial depolarization vector (RA to apex direction).

2. What is the recommended electrode-skin impedance for optimal signal quality? a) <2 kΩ b) <5 kΩ c) <10 kΩ d) <20 kΩ

   Answer: b) <5 kΩ (ideally <2 kΩ) - higher impedance increases baseline noise and reduces signal amplitude.

3. A QTc of 520 ms indicates: a) Normal finding b) Borderline prolongation, no action needed c) Significant prolongation with Torsades risk d) Measurement error

   Answer: c) QTc >500 ms indicates significant Torsades risk requiring intervention.

Intermediate Level (Clinical Application)

Short Answer Questions:

1. A patient's cardiac monitor displays chaotic baseline oscillations after repositioning. How would you differentiate motion artifact from ventricular fibrillation?

   Model Answer: Assess the patient clinically - check pulse, level of consciousness, and blood pressure. Motion artifact is benign and the patient will be hemodynamically stable with a palpable pulse. Additionally, check pulse oximetry plethysmograph for regular waveform. Examine the rhythm strip for regularity within the chaos (VF has irregular coarse or fine deflections). Check multiple leads - artifact often affects one lead more than others. If any doubt remains and patient unresponsive, treat as VF per ARC guidelines.

2. Describe three strategies to reduce alarm fatigue in the ICU.

   Model Answer:

   1. Individualize alarm parameters - Adjust thresholds based on patient baseline (e.g., lower bradycardia threshold for beta-blocked patients)
   2. Implement appropriate alarm delays - Non-critical alarms (tachycardia, bradycardia) can have 10-30 second delays while VF/asystole remain immediate
   3. Optimize signal quality - Regular electrode replacement (24-48 hours), proper skin preparation, cable management to reduce artifact and false alarms

Exam Level (CICM Second Part)

Extended Matching Questions:

For each clinical scenario, select the most likely cause of ECG abnormality:

Options: A. Motion artifact B. 60 Hz interference C. Electrode displacement D. Lead reversal E. Baseline wander F. Hyperkalemia G. Electrode-skin impedance

Scenarios:

1. Fine, regular oscillations on all leads at 60 cycles per second
2. Sudden appearance of "anterior STEMI" in a stable patient after turning
3. Slow undulation of baseline worse during patient's respiratory cycle
4. Inverted P waves and QRS complexes in lead I only

Answers:

1. B (60 Hz interference)
2. C (Electrode displacement mimicking STEMI)
3. E (Baseline wander from respiration)
4. D (Right arm-Left arm lead reversal)

---

SAQ Practice

SAQ 1: ECG Monitoring Principles and Troubleshooting

Question: You are the ICU registrar called to review a patient whose cardiac monitor is displaying "VT" alarms repeatedly. The patient appears clinically well with normal consciousness and palpable pulse.

a) Describe the principles of ECG signal acquisition from skin electrodes to monitor display. (6 marks)

b) List the systematic approach to troubleshooting this apparent false alarm. (8 marks)

c) Discuss strategies for alarm optimization in the ICU and the concept of alarm fatigue. (6 marks)

Model Answer:

a) Principles of ECG Signal Acquisition (6 marks)

Signal Origin (1 mark):

• ECG records potential differences generated by summated cardiac myocyte depolarization/repolarization
• Signal amplitude 0.5-3 mV at skin surface

Electrode-Skin Interface (1.5 marks):

• Ag/AgCl electrodes with electrolyte gel conduct ionic current
• Stratum corneum has high impedance; skin preparation reduces impedance to <5 kΩ
• Half-cell potential of electrode provides stable reference

Signal Transmission and Amplification (1.5 marks):

• Lead wires connect electrodes to patient cable
• Differential amplification (1000x gain) measures difference between electrodes
• Common Mode Rejection Ratio >100 dB rejects environmental interference (power line, electromagnetic)

Signal Processing (1 mark):

• Filtering: High-pass (0.05-0.5 Hz) removes baseline wander, low-pass (40-150 Hz) removes high-frequency noise
• Notch filter removes 50/60 Hz power line interference
• Analog-to-digital conversion at 250-500 Hz sampling rate

Display (1 mark):

• Waveform display with sweep speed (typically 25 mm/s)
• Automated analysis algorithms for rate, rhythm, arrhythmia detection
• Alarm generation based on programmed thresholds

b) Systematic Troubleshooting Approach (8 marks)

Step 1: Clinical Assessment (2 marks):

• Confirm patient is hemodynamically stable (conscious, palpable pulse, acceptable BP)
• Verify VT is false alarm, not genuine arrhythmia being tolerated
• Check pulse oximetry plethysmograph for regular rhythm
• Exclude patient factors (shivering, tremor, movement, seizure)

Step 2: ECG Analysis (2 marks):

• Examine rhythm strip for characteristics of artifact vs true VT
• VT: Wide, regular QRS complexes with capture beats, fusion beats, AV dissociation
• Artifact: Irregularity within the "wide complexes," normal QRS visible between disturbances
• Check multiple leads - artifact often localized to one lead; true VT appears in all leads

Step 3: Equipment Check (2 marks):

• Check electrode adhesion and gel condition
• Verify lead wire connections to electrodes and patient cable
• Inspect cable integrity (damage, fraying)
• Replace suspicious electrodes/cables

Step 4: Signal Optimization (1 mark):

• Clean and lightly abrade skin before reapplying electrodes
• Ensure electrodes placed on stable areas (avoid muscles, joints)
• Secure lead wires to reduce movement

Step 5: System Verification and Documentation (1 mark):

• Compare with another lead or 12-lead ECG
• Document troubleshooting steps
• Consider adjusting alarm parameters if appropriate
• Report recurrent issues to biomedical engineering

c) Alarm Optimization and Alarm Fatigue (6 marks)

Definition of Alarm Fatigue (1 mark):

• Sensory overload causing delayed or absent response to clinical alarms
• 72-99% of ICU cardiac alarms are false or non-actionable
• Average 150-400 alarms per patient per day

Consequences (1 mark):

• Delayed response to true critical events
• Documented patient deaths from missed VF/VT
• Nursing stress, burnout
• Identified as 3rd leading cause of sentinel events (Joint Commission)

Optimization Strategies (4 marks):

1. Parameter Individualization (1 mark):

   • Adjust alarm thresholds to patient baseline
   • Example: Lower bradycardia threshold for beta-blocked patients
   • Review and adjust within 2 hours of admission, then daily

2. Appropriate Alarm Delays (1 mark):

   • Immediate: VF, VT, asystole (no delay)
   • 10-30 seconds: Tachycardia, bradycardia
   • 60+ seconds: ST changes, technical alarms
   • Reduces nuisance alarms without compromising safety

3. Signal Quality Optimization (1 mark):

   • Regular electrode replacement (24-48 hours)
   • Proper skin preparation
   • Cable management
   • Appropriate filter selection

4. Smart Alarm Algorithms and Multidisciplinary Approach (1 mark):

   • Modern monitors integrate multiple parameters to reduce false alarms
   • Regular staff education and competency assessment
   • Multidisciplinary alarm committee
   • Alarm escalation protocols
   • Incident reporting and learning

---

SAQ 2: QTc Monitoring and Derived Indices

Question: A 55-year-old patient is admitted to ICU with severe sepsis and has been started on ciprofloxacin and metoclopramide. On day 2, the nurse reports the QTc is 510 ms.

a) Describe the different methods for calculating QTc and their relative accuracy. (5 marks)

b) Outline the ICU factors that contribute to QT prolongation and the drugs commonly implicated. (7 marks)

c) Discuss heart rate variability (HRV) as a derived index in cardiac monitoring, including its physiological basis and clinical applications. (8 marks)

Model Answer:

a) QTc Calculation Methods (5 marks)

Importance of Correction (1 mark):

• QT interval is rate-dependent (longer at slower heart rates)
• Correction allows comparison across different heart rates
• Manual measurement: From QRS onset to T wave end, in lead with longest QT

Bazett Formula (1 mark):

• QTc = QT / √RR (RR in seconds)
• Most commonly used but least accurate
• Overestimates QTc at high heart rates (>100 bpm)
• Underestimates QTc at low heart rates (<60 bpm)
• Appropriate only for heart rates 60-100 bpm

Fridericia Formula (1 mark):

• QTc = QT / ∛RR
• More accurate than Bazett at extreme heart rates
• Preferred in ICU settings with tachycardia/bradycardia
• Recommended by many guidelines as default correction

Framingham Formula (1 mark):

• QTc = QT + 0.154(1 - RR)
• Linear correction method
• Less affected by heart rate extremes
• Derived from large population study

Hodges Formula (0.5 marks):

• QTc = QT + 1.75(HR - 60)
• Linear, uses heart rate directly
• Simple to apply clinically

Automated vs Manual (0.5 marks):

• Modern monitors calculate QTc automatically
• Accuracy depends on correct T wave identification
• Manual verification recommended for borderline or critical values

b) ICU Factors and Drugs Causing QT Prolongation (7 marks)

Drug Categories (4 marks):

Electrolyte Abnormalities (1.5 marks):

• Hypokalemia: Most common ICU cause, direct effect on repolarization
• Hypomagnesemia: Often accompanies hypokalemia, cofactor for potassium channels
• Hypocalcemia: Prolongs plateau phase of action potential

Other ICU Factors (1.5 marks):

• Bradycardia: QT prolongation more pronounced at slow rates (pause-dependent Torsades)
• Myocardial ischemia: Alters repolarization
• Hypothermia: Prolongs all intervals including QT
• Hypothyroidism: Slowed cardiac conduction
• Intracranial pathology: Autonomic effects on repolarization
• Congenital long QT syndrome: May present during stress/illness

This Patient's Risk (contribution marks included above):

• Ciprofloxacin: Fluoroquinolone, QT prolongation risk
• Metoclopramide: Antiemetic with hERG channel effects
• Sepsis: Electrolyte disturbances, inflammation
• Combined risk requires immediate action

c) Heart Rate Variability (HRV) (8 marks)

Physiological Basis (2.5 marks):

• Definition: Beat-to-beat variation in RR intervals reflecting autonomic nervous system modulation
• Parasympathetic influence: Vagal activity causes rapid, beat-to-beat changes; high-frequency oscillations (0.15-0.4 Hz)
• Sympathetic influence: Slower modulation; low-frequency oscillations (0.04-0.15 Hz)
• Baroreflex: Contributes to both LF and HF components through BP regulation
• Central mechanisms: Brainstem cardiovascular centers integrate inputs

Time-Domain Measures (1.5 marks):

Frequency-Domain Measures (1.5 marks):

Clinical Applications in ICU (2 marks):

1. Sepsis Prognostication:

   • Reduced HRV (SDNN <50 ms) predicts mortality
   • Loss of variability may precede clinical deterioration by hours
   • Sensitivity 77%, specificity 88% for adverse outcome

2. Post-MI Risk Stratification:

   • SDNN <70 ms associated with 3.2x mortality risk
   • Standard component of risk assessment

3. Weaning Assessment:

   • Improved HRV during spontaneous breathing trial predicts success
   • LF/HF ratio changes indicate stress response

4. Brain Death Assessment:

   • Absent HRV supports diagnosis
   • Loss of respiratory sinus arrhythmia

Limitations (0.5 marks):

• Requires sinus rhythm (AF, frequent ectopy invalidate)
• Short recordings less reliable than 24-hour analysis
• Medications (beta-blockers, sedatives) affect HRV

---

Viva Scenarios

Viva 1: ECG Monitoring Technical Principles and Artifact Management

Opening Stem: "This viva concerns cardiac monitoring in the ICU. Let's begin with the technical aspects of ECG acquisition."

---

Examiner: Can you explain how the ECG signal is acquired from the patient?

Candidate: The ECG records potential differences generated by the summated electrical activity of cardiac myocytes during depolarization and repolarization. The signal amplitude at the skin surface is approximately 0.5 to 3 millivolts.

Surface electrodes, typically silver/silver chloride with electrolyte gel, are attached to the skin. The electrode-skin interface is critical; the stratum corneum of the epidermis has high electrical impedance, ideally kept below 5 kilohms with proper skin preparation.

The electrodes are connected via lead wires to a patient cable, which transmits the signal to the monitor. The monitor uses differential amplification with approximately 1000-fold gain to amplify the small cardiac signal. Differential amplification measures the difference between electrodes, which helps reject common-mode noise such as power line interference. A high Common Mode Rejection Ratio of greater than 100 dB is desirable.

Examiner: Good. What signal processing occurs before the ECG is displayed?

Candidate: Several filtering steps are applied. A high-pass filter removes baseline wander; this is set at 0.05 Hz in diagnostic mode but 0.5 Hz in monitoring mode for more aggressive artifact reduction. A low-pass filter removes high-frequency noise; set at 150 Hz for diagnostic and 40 Hz for monitoring mode.

A notch filter removes power line interference at 50 Hz in Australia and New Zealand or 60 Hz in other countries. It's important to note that the monitoring mode's more aggressive filtering can distort the ST segment, which is why diagnostic mode should be used for ischemia assessment.

The analog signal is then digitized using analog-to-digital conversion at sampling rates of 250 to 500 Hz, respecting the Nyquist theorem that sampling must be at least twice the highest frequency of interest.

Examiner: This patient has repeated VT alarms but appears clinically stable. How would you approach this?

Candidate: I would approach this systematically. First, clinical assessment: confirm the patient is hemodynamically stable with normal consciousness and palpable pulse. I would check the pulse oximetry plethysmograph for a regular waveform, which suggests the cardiac rhythm is actually regular despite the monitor alarm.

Second, I would analyse the ECG itself. Motion artifact can mimic VT but typically has irregularity within the wide complexes, may show normal QRS complexes visible between disturbances, and often affects one lead more than others. True VT shows regular wide QRS complexes, may have capture or fusion beats, and appears consistently across all leads.

Third, equipment check: I would examine electrode adhesion, gel condition, lead wire connections, and cable integrity. I would replace any suspicious electrodes.

Fourth, signal optimization: clean and lightly abrade the skin, ensure electrodes are placed on stable areas away from muscles and joints, and secure the lead wires.

Finally, I would document the troubleshooting and consider adjusting alarm parameters if this is a recurring issue.

Examiner: The artifact persists despite electrode replacement. What are the differential causes of what appears to be "ventricular activity" on the monitor?

Candidate: Several conditions can cause this appearance:

Motion artifact from patient movement, shivering, or tremor is the most common cause. This can be addressed by treating the underlying cause, such as warming a hypothermic patient, and by repositioning electrodes.

Muscle artifact from a tremor associated with conditions like Parkinson's disease or from seizure activity can produce high-frequency oscillations.

Lead wire or cable artifact can occur if cables are damaged or connections are loose.

High electrode-skin impedance due to dried gel, poor electrode adhesion, or diaphoresis.

External interference from nearby electrical equipment.

I would also consider whether this could be real arrhythmia that the patient is tolerating, such as accelerated idioventricular rhythm, so I would obtain a 12-lead ECG for definitive assessment.

Examiner: Tell me about alarm fatigue.

Candidate: Alarm fatigue is sensory overload leading to delayed or absent response to clinical alarms. It's a significant patient safety issue.

The epidemiology is concerning: 72 to 99% of ICU cardiac alarms are false or non-actionable, and there are typically 150 to 400 alarms per patient per day. The Joint Commission identified alarm fatigue as the third leading cause of sentinel events, and there are documented patient deaths from missed VF due to alarm desensitization.

Contributing factors include technical issues like artifact and poor signal quality, inappropriate default thresholds, redundant alarms from multiple devices, and the sheer volume overwhelming nursing staff.

Consequences include delayed response to true critical events, nursing stress and burnout, reduced alarm credibility, and family distress.

Examiner: How would you address alarm fatigue in your ICU?

Candidate: I would implement a multi-pronged approach:

First, parameter individualization: adjust alarm thresholds based on the patient's baseline. For example, a patient on beta-blockers may need a lower bradycardia threshold. This should be reviewed within 2 hours of admission and daily thereafter.

Second, appropriate alarm delays: VF and asystole alarms should remain immediate, but tachycardia and bradycardia alarms can have 10 to 30 second delays, and ST changes can have 60 second delays. This reduces nuisance alarms without compromising safety.

Third, signal quality optimization: regular electrode replacement every 24 to 48 hours, proper skin preparation, and good cable management.

Fourth, institutional measures: staff education on alarm interpretation, multidisciplinary alarm committee to review alarm data, escalation protocols, and incident reporting with learning.

Fifth, technology solutions: modern monitors with smart algorithms that integrate multiple parameters to reduce false alarms, and consideration of secondary alarming to mobile devices with appropriate escalation.

---

Viva 2: QTc Monitoring and Clinical Decision Support

Opening Stem: "A 65-year-old patient with pneumonia has been started on intravenous levofloxacin. The nurse reports the QTc has increased from 430 ms at admission to 495 ms today."

---

Examiner: What is the significance of this QTc change?

Candidate: This is concerning. The QTc has increased by 65 milliseconds, which is a significant change. A QTc greater than 500 ms is associated with high risk of Torsades de Pointes, and some guidelines consider an increase of more than 60 ms from baseline to be significant regardless of the absolute value.

Levofloxacin, a fluoroquinolone antibiotic, is a known QT-prolonging medication. It inhibits the hERG potassium channel, which is responsible for the delayed rectifier current during cardiac repolarization.

I would want to know if there are other contributing factors such as electrolyte disturbances, other QT-prolonging medications, or underlying cardiac disease.

Examiner: What is the mechanism of drug-induced QT prolongation and Torsades de Pointes?

Candidate: Drug-induced QT prolongation occurs primarily through inhibition of the hERG potassium channel, which conducts the rapid component of the delayed rectifier potassium current, IKr.

Blocking this channel prolongs the action potential duration, which is reflected as QT prolongation on the surface ECG. This creates inhomogeneity of repolarization across the myocardium, which is the substrate for triggered activity.

Early afterdepolarizations, particularly in Purkinje fibers, can trigger premature ventricular complexes. These can initiate Torsades de Pointes, a polymorphic ventricular tachycardia with a characteristic twisting axis that can degenerate into ventricular fibrillation.

Risk is higher with bradycardia, which is why this is sometimes called pause-dependent Torsades. Female sex, structural heart disease, electrolyte disturbances, and genetic susceptibility also increase risk.

Examiner: How would you manage this patient?

Candidate: Immediate actions would include:

First, checking and correcting electrolytes. I would measure potassium, magnesium, and calcium. Hypokalemia and hypomagnesemia are common in ICU patients and potentiate QT prolongation. I would aim for potassium greater than 4 mmol/L and magnesium greater than 1 mmol/L.

Second, reviewing medications. Levofloxacin is likely the precipitant. I would assess whether it's essential or whether an alternative antibiotic with less QT effect could be used, depending on the organism and sensitivities.

Third, reviewing other medications for additional QT-prolonging drugs such as antiemetics like ondansetron or metoclopramide, antipsychotics, or other antimicrobials.

Fourth, enhancing monitoring: ensure continuous cardiac monitoring with QT trending, and set appropriate alarms for QTc exceeding 500 ms.

If the QTc exceeds 500 ms or Torsades occurs:

• Stop the offending drug
• Correct electrolytes aggressively
• Give intravenous magnesium 2 grams even if serum magnesium is normal
• If bradycardia-dependent, consider temporary pacing or isoprenaline to increase heart rate
• If Torsades occurs, this is treated as polymorphic VT: if pulseless, defibrillation; if with pulse, magnesium and rate support

Examiner: Can you discuss the different QTc correction formulas?

Candidate: The most commonly used is Bazett's formula: QTc equals QT divided by the square root of the RR interval in seconds. However, it has significant limitations. It overestimates QTc at high heart rates and underestimates at low heart rates. It's really only accurate between 60 and 100 beats per minute.

Fridericia's formula uses the cube root of RR instead of the square root. It's more accurate at extreme heart rates and is increasingly recommended as the preferred correction, particularly in ICU settings where tachycardia is common.

The Framingham formula is a linear correction: QTc equals QT plus 0.154 times (1 minus RR). It was derived from a large population study.

Hodges formula is also linear: QTc equals QT plus 1.75 times (heart rate minus 60).

In practice, for critically ill patients with abnormal heart rates, I prefer Fridericia or a linear correction. Automated monitor calculations may use any of these formulas, so it's important to know which one your equipment uses.

Examiner: Tell me about heart rate variability monitoring.

Candidate: Heart rate variability, or HRV, measures the beat-to-beat variation in RR intervals. It reflects autonomic nervous system modulation of cardiac function.

The parasympathetic nervous system causes rapid, beat-to-beat changes in heart rate, producing high-frequency oscillations between 0.15 and 0.4 Hz. This includes respiratory sinus arrhythmia.

The sympathetic nervous system produces slower modulation, contributing to low-frequency oscillations between 0.04 and 0.15 Hz, though this band has mixed sympathetic and parasympathetic contributions.

Time-domain measures include SDNN, the standard deviation of NN intervals, which reflects overall HRV. An SDNN less than 50 milliseconds indicates high risk. RMSSD and pNN50 reflect parasympathetic activity.

Examiner: What are the clinical applications of HRV in the ICU?

Candidate: The main applications are:

First, sepsis prognostication. Reduced HRV in sepsis predicts mortality. Loss of heart rate variability may precede clinical deterioration by hours, potentially enabling earlier intervention. The sensitivity is around 77% and specificity 88% for adverse outcomes.

Second, post-MI risk stratification. An SDNN less than 70 milliseconds is associated with a 3.2-fold increase in mortality risk.

Third, weaning from mechanical ventilation. Improved HRV during a spontaneous breathing trial suggests the patient is tolerating the trial and predicts successful extubation. Changes in the LF/HF ratio indicate the stress response to weaning.

Fourth, brain death assessment. Absent HRV, particularly loss of respiratory sinus arrhythmia, supports the diagnosis of brain death.

The limitations are important to acknowledge: it requires sinus rhythm, so patients with atrial fibrillation or frequent ectopy cannot be assessed. Medications like beta-blockers and sedatives affect HRV. Short recording periods are less reliable than 24-hour recordings.

Examiner: How might cardiac monitoring integrate with clinical decision support systems in future ICU practice?

Candidate: Integration is evolving in several directions:

Automated sepsis detection combines heart rate data, including trends and HRV, with respiratory rate, blood pressure, temperature, and laboratory values to generate early sepsis alerts. Evidence suggests this can reduce time to appropriate therapy.

Ischemia alert systems can trigger automatic 12-lead ECG acquisition when ST-segment changes are detected, with immediate notification to the cardiology team.

Arrhythmia management protocols can calculate risk scores. For example, new atrial fibrillation can trigger CHA2DS2-VASc calculation and anticoagulation recommendations.

Predictive analytics using machine learning may predict cardiac arrest or deterioration hours before it occurs, based on subtle changes in heart rate patterns and variability that humans cannot detect.

The challenges include validation requirements for new algorithms, regulatory approval, integration with existing hospital systems, and the risk of additional alert fatigue if not implemented carefully.